Income‐related inequities persist in the initiation of evidence‐based pharmacologic therapies (e.g., ACE‐inhibitors, beta‐blockers, statins) for acute myocardial infarction, particularly among male patients. The gene discussed is ACE; the disease is acute myocardial infarction.